ZA85910B - A novel anhydrous,stable,crystalline o-form of prazosin hydrochloride and a novel process for the preparation of said crystalline o-form - Google Patents

A novel anhydrous,stable,crystalline o-form of prazosin hydrochloride and a novel process for the preparation of said crystalline o-form

Info

Publication number
ZA85910B
ZA85910B ZA85910A ZA85910A ZA85910B ZA 85910 B ZA85910 B ZA 85910B ZA 85910 A ZA85910 A ZA 85910A ZA 85910 A ZA85910 A ZA 85910A ZA 85910 B ZA85910 B ZA 85910B
Authority
ZA
South Africa
Prior art keywords
crystalline
novel
stable
preparation
prazosin hydrochloride
Prior art date
Application number
ZA85910A
Other languages
English (en)
Inventor
Stig Olof Engelbert
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of ZA85910B publication Critical patent/ZA85910B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA85910A 1984-06-25 1985-02-06 A novel anhydrous,stable,crystalline o-form of prazosin hydrochloride and a novel process for the preparation of said crystalline o-form ZA85910B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI842544A FI79107C (fi) 1984-06-25 1984-06-25 Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.

Publications (1)

Publication Number Publication Date
ZA85910B true ZA85910B (en) 1985-09-25

Family

ID=8519293

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA85910A ZA85910B (en) 1984-06-25 1985-02-06 A novel anhydrous,stable,crystalline o-form of prazosin hydrochloride and a novel process for the preparation of said crystalline o-form

Country Status (17)

Country Link
US (2) US4739055A (en:Method)
JP (1) JPS6115881A (en:Method)
AT (1) AT389117B (en:Method)
AU (1) AU566814B2 (en:Method)
BE (1) BE900925A (en:Method)
CH (1) CH661045A5 (en:Method)
DE (1) DE3429415A1 (en:Method)
FI (1) FI79107C (en:Method)
FR (1) FR2567124B1 (en:Method)
GB (1) GB2160861B (en:Method)
IL (1) IL73267A (en:Method)
IT (1) IT1224142B (en:Method)
LU (1) LU85616A1 (en:Method)
NL (1) NL8403250A (en:Method)
NZ (1) NZ209962A (en:Method)
PT (1) PT79411B (en:Method)
ZA (1) ZA85910B (en:Method)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3683760D1 (de) * 1986-03-21 1992-03-12 Heumann Pharma Gmbh & Co Kristalline, wasserfreie sigma -form von 2-(4-(2-furoyl-(2-piperazin)-1-yl)-4-amino-6,7-dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
JP2756846B2 (ja) * 1989-12-28 1998-05-25 住化ファインケム株式会社 無水のε型結晶体２―〔４―（２―フロイル）ピペラジン―１―イル〕―４―アミノ―６，７―ジメトキシキナゾリン塩酸塩及びその製造方法
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
EP1953162B9 (de) * 2001-02-24 2012-10-31 Boehringer Ingelheim Pharma GmbH & Co. KG Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) * 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20080251A1 (es) * 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP2016079A1 (de) 2006-05-04 2009-01-21 Boehringer Ingelheim International GmbH Polymorphe
JP5769966B2 (ja) * 2007-08-17 2015-08-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｆａｂ関連疾患治療用プリン誘導体
AR071175A1 (es) 2008-04-03 2010-06-02 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
ES2764251T3 (es) * 2008-08-15 2020-06-02 Boehringer Ingelheim Int Inhibidores de DPP-4 para uso en el tratamiento de curación de heridas en pacientes diabéticos
JP2012502081A (ja) 2008-09-10 2012-01-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糖尿病及び関連症状の治療のための組み合わせ治療
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
AU2009331471B2 (en) 2008-12-23 2015-09-03 Boehringer Ingelheim International Gmbh Salt forms of organic compound
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
JP2013512229A (ja) 2009-11-27 2013-04-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 遺伝子型が同定された糖尿病患者のリナグリプチン等のｄｄｐ−ｉｖ阻害薬による治療
EP2566469B1 (en) 2010-05-05 2022-12-21 Boehringer Ingelheim International GmbH Combination therapy
EP3366304B1 (en) 2010-06-24 2020-05-13 Boehringer Ingelheim International GmbH Diabetes therapy
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
DK2731947T3 (en) 2011-07-15 2019-04-23 Boehringer Ingelheim Int SUBSTITUTED DIMERIC QUINAZOLINE DERIVATIVE, PREPARATION AND USE thereof IN PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF TYPE I AND TYPE II DIABETES
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
ES2929025T3 (es) 2012-05-14 2022-11-24 Boehringer Ingelheim Int Linagliptina, un derivado de xantina como inhibidor de dpp-4, para su uso en el tratamiento del SRIS y/o de la septicemia
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
JP6615109B2 (ja) 2014-02-28 2019-12-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｄｐｐ−４阻害薬の医学的使用
CN109310697A (zh) 2016-06-10 2019-02-05 勃林格殷格翰国际有限公司 利格列汀和二甲双胍的组合

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE156532C (en:Method) *
US2969375A (en) * 1961-01-24 Certification of correction
NL54420C (en:Method) * 1937-05-25
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives
US3433788A (en) * 1966-04-27 1969-03-18 Union Carbide Corp Process for recovery of amines from aqueous solutions by solvent treatment and distillation
US3421983A (en) * 1967-03-07 1969-01-14 Lummus Co Azeotropic distillation of aqueous toluene diamine
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3743672A (en) * 1970-05-27 1973-07-03 Halcon International Inc Separation of water in alkylene glycol mono and diester purification by azeotropic distillation
GB1308718A (en) * 1970-07-01 1973-03-07 Sir Soc Italiana Resine Spa Method of separating vinyl acetate from liquid mixtures
IT956765B (it) * 1972-06-22 1973-10-10 Montedison Spa Procedimento per la purificazione di 1 3 diossolano
US3935213A (en) * 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
FI64367C (fi) * 1980-02-26 1986-08-05 Orion Yhtymae Oy Foerfarande foer framstaellning av alfa-form av prazosinhydroklorid

Also Published As

Publication number Publication date
LU85616A1 (fr) 1985-06-04
FR2567124A1 (fr) 1986-01-10
FI842544L (fi) 1985-12-26
FR2567124B1 (fr) 1990-09-21
FI79107C (fi) 1989-11-10
GB2160861B (en) 1987-11-18
IT1224142B (it) 1990-09-26
FI842544A0 (fi) 1984-06-25
AU566814B2 (en) 1987-10-29
FI79107B (fi) 1989-07-31
US4873330A (en) 1989-10-10
PT79411B (en) 1986-09-15
GB2160861A (en) 1986-01-02
JPH0481993B2 (en:Method) 1992-12-25
GB8424999D0 (en) 1984-11-07
ATA344184A (de) 1989-03-15
AU3451084A (en) 1986-01-02
BE900925A (fr) 1985-02-15
AT389117B (de) 1989-10-25
PT79411A (en) 1984-11-01
NZ209962A (en) 1987-06-30
DE3429415C2 (en:Method) 1990-05-03
DE3429415A1 (de) 1986-01-02
NL8403250A (nl) 1986-01-16
US4739055A (en) 1988-04-19
CH661045A5 (de) 1987-06-30
JPS6115881A (ja) 1986-01-23
IL73267A0 (en) 1985-01-31
IL73267A (en) 1988-06-30
IT8423292A0 (it) 1984-10-24

Similar Documents

Publication Publication Date Title
ZA85910B (en) A novel anhydrous,stable,crystalline o-form of prazosin hydrochloride and a novel process for the preparation of said crystalline o-form
HUT38361A (en) Process for preparing new crystalline modifications
HUT44257A (en) Process for preparing crystalline cefalosporinhydrate
YU191188A (en) Process for preparing new ammonia compounds
PT79963A (en) Process for the preparation of asymetric diesthers
PT81463A (en) Process for preparing novel 5-amino-4-hidroxyvalerylderivatives
DE3560511D1 (en) Pleuromutilin derivatives, process for their preparation and their use
ZA862929B (en) Process for preparing(z)-1-phenyl-1-diethylaminocarbonyl-2-aminomethyl-cyclopropane hydrochloride
HUT36805A (en) Process for preparing 1-cyclopropyl-quinoline- and -naphthyridine-carboxylic acid derivatives
YU156985A (en) Process for producing ammonia
YU228688A (en) Process for preparing new ammonia compounds
EP0164786A3 (en) A process for the preparation of p-isononanoyloxybenzenenesulphonate
GB2167066B (en) Process for producing urea
PT81522A (en) Process for preparing basic v1-vasopressin antagonists
ZA878215B (en) Process for preparing urea
DE3665875D1 (en) Crystalline polyester-imides, process for production thereof, and use thereof
PT81510B (en) Process for preparing v1-vasopressin antagonists
PT85372A (en) Bisucaderin a process for producing this compound and its use as a medicament
YU45030B (en) Process for preparing crystalline cimetidine
IL84403A (en) Process for the preparation of a nitrobenzoylalkane-sulfonamide
HUT36800A (en) Process for preparing carbamidic acid derivatives
DE3561057D1 (en) Process for preparing 1-naphthyl amine
DE3564274D1 (en) Novel ethyl benzylphosphinate derivatives, process for production thereof, and their use as calcium antagonist
YU5488A (en) Process for producing herbicidal pyridinsulphonyl ureas
EP0253360A3 (en) Process for preparing nitriles